GHK-Cu ist eines der am besten wissenschaftlich untersuchten Anti-Aging-Peptide berhaupt mit einer Forschungsgeschichte, die bis 1973 zurckreicht
It is known that AngII binding at the AT 1 subtype activates the NADPH oxydase complex, thus providing a major source of ROS (104106)
All these processes lead our cells to produce residual substances-or free radicals
Retrieved May 15, 2025, from ChemicalBook (BPC-157 Product Page): ChemicalBook
Dose-response studies indicate that BPC-157 at 800 ng/kg produces near-complete ulcer healing with thick granulation tissue formation, demonstrating potent effects at remarkably low doses

Metabolism & Elimination Both peptides undergo similar metabolic pathways despite their structural differences: GLP1 metabolism: Proteolytic cleavage of the peptide backbone across multiple tissues Sequential beta-oxidation of the fatty acid side chain No organ-specific metabolism with degradation occurring in multiple tissues simultaneously Six identified metabolites in human plasma, with metabolite P3 comprising approximately 7.7% of circulating drug-related material Intact peptide predominance with 69-83% of circulating material remaining as intact GLP1 Cagrilintide metabolism: Similar proteolytic pathways to GLP1 due to peptide structure Fatty acid chain processing through beta-oxidation mechanisms Albumin-mediated protection reducing enzymatic access to the peptide backbone Reversible albumin binding allowing gradual release and metabolism No specific organ predominance for metabolic clearance The remarkably similar half-lives of both peptides (159-195 hours for cagrilintide, 145-165 hours for GLP1) enable synchronized pharmacokinetic profiles ideal for fixed-dose combination therapy
